CD40 and melanoma: While the loss of CD40 copy number is very rare in melanoma patients (~ 1.25%, TCGA), ~ 50% of melanoma patients exhibit CD40 copy number gains (Fig. 7 b) and thus may be prone to exhibit enhanced inducible expression of CD40.